Accelerate medical breakthroughs by ending disease earmarks

Nature Reviews Genetics

Volumn 11, Issue 5, 2010, Pages 310-311

  Terry, Sharon F ^a  

^a PXE International and Genetic Alliance BioBank   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CRYOPYRIN; INTERLEUKIN 1; LOSARTAN; LOSARTAN POTASSIUM; RITUXIMAB; TRANSFORMING GROWTH FACTOR BETA;

B LYMPHOCYTE; CYTOKINE PRODUCTION; DIABETES MELLITUS; DRUG RESEARCH; DRUG TARGETING; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC DISORDER; GENOMICS; GOUT; HUMAN; HYPERTENSION; INFLAMMATION; JUVENILE RHEUMATOID ARTHRITIS; LUNG DISEASE; MARFAN SYNDROME; NONHODGKIN LYMPHOMA; NOTE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

BIOMEDICAL RESEARCH; CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES; DRUG THERAPY; GENOME, HUMAN; HUMANS; NEOPLASMS;

EID: 77951116347     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg2782     Document Type: Note

References (8)

1. Whalen, J. FDA approves a novel Novartis drug. Wall Street Journal B1 (19 Jun 2009).
2. Collins, F. S. Unprecedented therapeutic opportunities for rare and neglected diseases. 2009 Genetic Alliance Annual Conference [online], http://www.geneticalliance.org/conference09.materials (2009).
3. Lachmann, H. J. et al. Use of canakinumab in the cryopyrin-associated periodic syndrome. N. Engl. J. Med. 360, 2416-2425 (2009).
4. McDermott, M. F. Rilonacept in the treatment of chronic inflammatory disorders. Drugs Today 45, 423-430 (2009).
5. Matt, P. et al. Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan? J. Thorac. Cardiovasc. Surg. 135, 389-394 (2008).
6. Is Inflammation the Root of All Disease?, UC Berkeley Wellness Letter [online], http://www.wellnessletter.com/html/wl/2008/wlFeatured0108.html.
7. Balkwill, F. & Mantovani A. Inflammation and cancer: back to Virchow? Lancet 357, 539-545 (2001).
8. Leaf, C. Why we are losing the war on cancer: and how we can win it. Fortune 77-92 (9 Mar 2004).